Evidence-based medicine in a nutshell. A guide to finding and using the best evidence in caring for patients.

Evidence-based medicine is the use of the best current evidence in making decisions about the care of individual patients. Practicing EBM requires recognition that in most encounters with patients, questions arise that should be answered to provide the patient with the best available medical care. Asking well-built clinical questions that contain 4 elements--a patient or problem, an intervention, a comparison intervention (if necessary), and an outcome--is an important step in practicing EMB. Once appropriate questions have been formulated, the best source for finding most types of best evidence is by searching the MEDLINE database by computer. MEDLINE searches have inherent software and operator limitations that make their reliability quite variable. One should be aware of these limitations and improve one's skills in searching. The Cochrane Collaboration Controlled Clinical Trials Registry contains more than 190,000 controlled clinical trials and is the best source of evidence about treatment. The quality (strength) of evidence is based on a hierarchy of evidence: results of systematic reviews of well-designed clinical studies, results of 1 or more well-designed clinical studies, results of large case series, expert opinion, and personal experience. Once the best evidence has been found, the EBM approach involves critically appraising the quality of the evidence, determining its magnitude and precision, and applying it to the specific patient. Guidelines to critically appraise and apply evidence are available. The clinical question, best evidence, and its critical appraisal should be saved in a format that can be easily retrieved for future use.

[1]  A. Marchetti,et al.  Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model. , 1996, Clinical therapeutics.

[2]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention B. What Were the Results and Will They Help Me in Caring for My Patients? , 1994 .

[3]  D L Sackett,et al.  Clinical recommendations using levels of evidence for antithrombotic agents. , 1995, Chest.

[4]  R. Brian Haynes,et al.  Research Paper: Performances of 27 MEDLINE systems tested by searches with clinical questions , 1994, J. Am. Medical Informatics Assoc..

[5]  E. Lesaffre,et al.  A 12–week treatment for dermatophyte toe onychomycosis terbinafine 250mg/day vs. itraconazole 200mg/day—a double‐blind comparative trial , 1996, The British journal of dermatology.

[6]  R. Auerbach,et al.  Histologic evaluation of nail clippings for diagnosing onychomycosis. , 1991, Archives of dermatology.

[7]  R. Heller,et al.  14. Modern methods of searching the medical literature , 1992 .

[8]  M. Bigby,et al.  Understanding and evaluating clinical trials. , 1996, Journal of the American Academy of Dermatology.

[9]  M. De Backer,et al.  Twelve weeks of continuous oral therapy for toenail onychomycosis caused by dermatophytes: a double-blind comparative trial of terbinafine 250 mg/day versus itraconazole 200 mg/day. , 1998, Journal of American Academy of Dermatology.

[10]  Christopher H Schmid,et al.  Summing up evidence: one answer is not always enough , 1998, The Lancet.

[11]  C. R. Daniel The diagnosis of nail fungal infection. , 1991, Archives of dermatology.

[12]  H. N. Liu,et al.  KONCPA: a new method for diagnosing tinea unguium. , 1993, Dermatology.

[13]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[14]  B. Elewski Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine. , 1997, Archives of dermatology.

[15]  H. Wulff,et al.  Rational diagnosis and treatment. , 1986, The Journal of medicine and philosophy.

[16]  Angello Jt,et al.  A cost/efficacy analysis of oral antifungals indicated for the treatment of onychomycosis: griseofulvin, itraconazole, and terbinafine. , 1997 .

[17]  D. Sackett,et al.  Evidence based medicine: what it is and what it isn't , 1996, BMJ.

[18]  R. Brian Haynes,et al.  Developing optimal search strategies for detecting clinically sound studies in MEDLINE. , 1994, Journal of the American Medical Informatics Association : JAMIA.

[19]  R. Hay Risk/benefit ratio of modern antifungal therapy: focus on hepatic reactions. , 1993, Journal of the American Academy of Dermatology.

[20]  R. Schopf,et al.  Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection , 1995, BMJ.

[21]  P. Krupp,et al.  Safety of oral terbinafine : Results of a postmarketing surveillance study in 25 884 Patients , 1997 .

[22]  R. Stern,et al.  An evaluation of method reporting and use in clinical trials in dermatology. , 1985, Archives of dermatology.

[23]  R. Haynes,et al.  Teaching clinicians to search MEDLINE: description and evaluation of a short course. , 1986, Research in medical education : proceedings of the ... annual Conference. Conference on Research in Medical Education.

[24]  K. A. McKibbon,et al.  Problems encountered by clinical end users of MEDLINE and GRATEFUL MED. , 1991, Bulletin of the Medical Library Association.

[25]  J. Fleiss Statistical methods for rates and proportions , 1974 .

[26]  B. Piraccini,et al.  Treatment of dermatophyte nail infections: an open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. , 1996, Journal of the American Academy of Dermatology.

[27]  N L Wilczynski,et al.  Quantitative comparison of pre-explosions and subheadings with methodologic search terms in MEDLINE. , 1994, Proceedings. Symposium on Computer Applications in Medical Care.

[28]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: I. How to Get Started , 1993 .

[29]  G. Guyatt,et al.  Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test: B. What Are the Results and Will They Help Me In Caring for My Patients? , 1994 .

[30]  C. Needham,et al.  Postmarketing surveillance of oral terbinafine in the UK: report of a large cohort study. , 1996, British journal of clinical pharmacology.

[31]  D. C. Hines,et al.  Clinical investigation: a guide to its evaluation. , 1969, American journal of obstetrics and gynecology.

[32]  D. Sackett,et al.  The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.

[33]  Alastair F Wright,et al.  MEDICAL STATISTICS ON MICROCOMPUTERS , 1991 .

[34]  R. Arenas,et al.  OPEN RANDOMIZED COMPARISON OE ITRACONAZOLE VERSUS TERBINAEINE IN ONYCHOMYCOSIS , 1995, International journal of dermatology.

[35]  P. Bossuyt,et al.  A systematic review of five systemic treatments for severe psoriasis , 1997, The British journal of dermatology.

[36]  B. Elewski Diagnostic techniques for confirming onychomycosis. , 1996, Journal of the American Academy of Dermatology.

[37]  G. Guyatt,et al.  Users' Guides to the Medical Literature: IX. A Method for Grading Health Care Recommendations , 1995 .

[38]  G. Grégoire,et al.  Discrepancies between meta-analyses and subsequent large randomized, controlled trials. , 1997, The New England journal of medicine.

[39]  R. Haynes,et al.  Searching MEDLINE for randomized clinical trials involving care of the newborn. , 1989, Pediatrics.

[40]  T. Greenhalgh How to Read a Paper: The Basics of Evidence-Based Medicine , 1997 .

[41]  G H Guyatt,et al.  USERS' GUIDES TO THE MEDICAL LITERATURE. II: HOW TO USE AN ARTICLE ABOUT THERAPY OR PREVENTION A. ARE THE RESULTS OF THE STUDY VALID ? , 1993 .

[42]  K. Dickersin,et al.  Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .

[43]  D. Sackett Evidence-Based Medicine: How to Practice and Teach EBM , 2018 .

[44]  K. Kohtamäki,et al.  Efficacy and safety of itraconazole in the long-term treatment of onychomycosis. , 1992, The Journal of antimicrobial chemotherapy.

[45]  J. Levron,et al.  [Example of active therapeutic follow-up: itraconazole]. , 1996, Therapie.

[46]  K J Rothman,et al.  A show of confidence. , 1978, The New England journal of medicine.

[47]  N L Wilczynski,et al.  Reasons for the loss of sensitivity and specificity of methodologic MeSH terms and textwords in MEDLINE. , 1995, Proceedings. Symposium on Computer Applications in Medical Care.

[48]  J. Ioannidis,et al.  Issues in comparisons between meta-analyses and large trials. , 1998, JAMA.

[49]  Rümke Cl Letter: Implications of the statement: No side effects were observed. , 1975 .

[50]  J. Leyden,et al.  Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial. , 1997, Journal of the American Academy of Dermatology.

[52]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: IV. How to Use an Article About Harm , 1994 .

[53]  E. van Doorslaer,et al.  Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany. , 1996, Dermatology.

[54]  D G Altman,et al.  Estimating with confidence , 1988, British medical journal.

[55]  D. Sackett,et al.  The Ends of Human Life: Medical Ethics in a Liberal Polity , 1992, Annals of Internal Medicine.

[56]  R. Davies Mycological tests and onychomycosis , 1968, Journal of clinical pathology.

[57]  R. Schopf,et al.  German randomized double–blind multicentre comparison of terbinafine and itraconazole for the treatment of toenail tinea infection , 1996, The British journal of dermatology.

[58]  T C Chalmers,et al.  Cumulative meta-analysis of therapeutic trials for myocardial infarction. , 1992, The New England journal of medicine.

[59]  W. Richardson,et al.  The well-built clinical question: a key to evidence-based decisions. , 1995, ACP journal club.

[60]  B. Elewski,et al.  Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other conditions. , 1997, Archives of dermatology.

[61]  J. Ioannidis,et al.  Large trials vs meta-analysis of smaller trials. How do their results compare? , 1997 .

[62]  P. Vanparys,et al.  Safety aspects of oral antifungal agents. , 1990, British journal of clinical practice. Supplement.

[63]  M. Bigby Ruling out the diagnosis. , 1996, Archives of dermatology.

[64]  J. Villar,et al.  Predictive ability of meta-analyses of randomised controlled trials , 1995, The Lancet.

[65]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: III. How to Use an Article About a Diagnostic Test A. Are the Results of the Study Valid? , 1994 .

[66]  G. Amsden,et al.  Current Issues in Onychomycosis , 1998, The Annals of pharmacotherapy.

[67]  N L Wilczynski,et al.  Assessment of methodologic search filters in MEDLINE. , 1993, Proceedings. Symposium on Computer Applications in Medical Care.